Panacea Index Logo

Command Palette

Search for a command to run...

Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature.

Current pharmaceutical design
January 1, 2022
Jimmy T Efird et al. (4 authors)
Journal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, Non-P.H.S.Human StudyClinical
Study Details

Study Goal

The researchers aimed to examine the interaction between vitamin D and corticosteroids as a potential explanation for inconsistent findings regarding vitamin D's benefit in hospitalized COVID-19 patients.

Results Summary

The study found that existing research on vitamin D and COVID-19 outcomes is inconsistent, with most studies being observational and not accounting for corticosteroid use. Small randomized trials have been insufficiently powered to balance corticosteroid use between study arms.

Population

Hospitalized COVID-19 patients, particularly those requiring oxygen and mechanical ventilation.

Effective Dosage

Not available

Duration

Not available

Interactions

Corticosteroids

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
vitamin D
decrease
immune modulation and inflammation
-
-
important immune-modulator with anti-inflammatory properties
#1
vitamin D
neutral
COVID-19 prevention and treatment
-
-
studied extensively in the prevention and treatment of COVID-19
#2
vitamin D
no change
overall benefit in patients hospitalized with COVID-19
patients hospitalized with COVID-19
inconsistent
findings have been inconsistent regarding its overall benefit
#3
Abstract

Vitamin D is an important immune-modulator with anti-inflammatory properties. While this prohormone has been studied extensively in the prevention and treatment of COVID-19, findings have been inconsistent regarding its overall benefit in patients hospitalized with COVID-19. Most studies to date have been observational in nature, not accounting for the use of corticosteroids. Furthermore, the few randomized clinical trials designed to examine the effect of vitamin D supplementation on COVID-19 outcomes have been relatively small and thus insufficiently powered to assure a balance of corticosteroid use between study arms. The current perspective addresses the interaction of vitamin D and corticosteroids as a potential explanation for the divergent results reported in the literature. Future research on vitamin D and COVID-19 will benefit by considering this interaction, especially among hospitalized patients requiring oxygen and mechanical ventilation.

Medical Subject Headings (MeSH)
Adrenal Cortex HormonesHumansSARS-CoV-2Vitamin DVitaminsCOVID-19 Drug Treatment
Study Links
Quality Scores
SafetyNot Assessed
Efficacy50/10
Quality60/10
Citation Metrics
Total Citations2
Citations/Year0.7
Relative Citation Ratio0.20
NIH Percentile10.2%
Research Impact Scores
APT Score0.25
Weight Score2.00
Normalized Score0.52
Related Supplements
Interaction of Vitamin D and Corticosteroid Use in Hospitali... | Panacea Index